I 
108TH CONGRESS 
2D SESSION 
H. R. 4682 
To amend the Public Health Service Act to provide for human embryonic 
stem cell research. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 24, 2004 
Mr. CASTLE (for himself, Ms. DEGETTE, Mr. DOOLEY of California, Mr. 
BASS, Mrs. BIGGERT, Mr. GIBBONS, Mr. GILCHREST, Mr. GREENWOOD, 
Mr. HOUGHTON, Mrs. JOHNSON of Connecticut, Mr. KIRK, Mr. KOLBE, 
Mr. LEACH, Mr. RAMSTAD, Mr. SHAYS, Ms. BALDWIN, Mr. BROWN of 
Ohio, Mr. EVANS, Mr. LANGEVIN, Mrs. MALONEY, Mr. WAXMAN, Mr. 
STARK, Mr. MOORE, Mrs. CAPPS, Mr. HOYER, and Ms. SOLIS) intro-
duced the following bill; which was referred to the Committee on Energy 
and Commerce 
A BILL 
To amend the Public Health Service Act to provide for 
human embryonic stem cell research. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Stem Cell Research 
Enhancement Act of 2004’’.
SEC. 2. HUMAN EMBRYONIC STEM CELL RESEARCH. 
Part H of title IV of the Public Health Service Act 
(42 U.S.C. 289 et seq.) is amended by inserting after sec-
tion 498C the following: 
‘‘SEC. 498D. HUMAN EMBRYONIC STEM CELL RESEARCH. 
‘‘(a) IN GENERAL.—Notwithstanding any other pro-
vision of law, the Secretary shall conduct and support re-
search that utilizes human embryonic stem cells in accord-
ance with this section. 
‘‘(b) REQUIREMENTS.—The Secretary shall conduct 
or support research that utilizes human embryonic stem 
cells if the following requirements are met: 
‘‘(1) The stem cells were derived from human 
embryos that have been donated from in vitro fer-
tilization clinics, were created for the purposes of 
fertility treatment, and were in excess of the clinical 
need of the individuals seeking such treatment. 
‘‘(2) Prior to the consideration of embryo dona-
tion and through consultation with the individuals 
seeking fertility treatment, it is determined that the 
embryos will never be implanted in a woman and 
would otherwise be discarded. 
‘‘(3) The individuals seeking fertility treatment 
donated the embryos with written informed consent 
and without receiving any financial or other induce-
ments to make the donation.
‘‘(c) GUIDELINES.—Not later than 60 days after the 
date of the enactment of this section, the Secretary, in 
consultation with the Director of NIH, shall promulgate 
guidelines to carry out this section. 
‘‘(d) DETERMINATION.—In determining whether this 
section authorizes or prohibits the conduct or support of 
research using a particular human embryonic stem cell 
line, the Secretary— 
‘‘(1) shall apply the requirements of subsection 
(b) regardless of the date on which the stem cell line 
is derived from a human embryo; and 
‘‘(2) shall apply the guidelines promulgated 
under this section only if the stem cell line is derived 
from a human embryo on or after the date described 
in subsection (c). 
‘‘(e) REPORTING REQUIREMENTS.—The Secretary 
shall annually prepare and submit to the appropriate com-
mittees of the Congress a report describing the activities 
carried out under this section during the preceding fiscal 
year, and including a description of whether and to what 
extent research under subsection (a) has been conducted 
in accordance with this section.’’. 
Æ